Cg. Stief et al., THE PHOSPHODIESTERASE-ISOENZYMES OF THE H UMAN URETER - CHARACTERIZATION AND FUNCTIONAL-SIGNIFICANCE, Aktuelle Urologie, 26(1), 1995, pp. 27-31
The existence of phosphodiesterase (PDE) isoenzymes in human ureter ti
ssue and the relaxant effect of different selective phosphodiesterase
inhibitors on human ureteral strips in vitro was evaluated. Isoenzyme
characterization was carried out after homogenizing and centrifuging u
reteral tissue. The supernatant fraction was applied to anion-exchange
DEAE-Sephacel chromatography and eluted using sodium acetate gradient
. Assay for PDE activity was then performed and peak fractions were ad
ded to different specific PDE activators and inhibitors. Three differe
nt PDE isoenzymes were characterized: PDE I (calmodulin-sensitive), PD
E II (cGMP-stimulated) and PDE IV (cAMP-specific). Relaxing potency of
PDE-inhibitors was measured on isolated ureteral muscle strips. Diffe
rent selective phosphodiesterase inhibitors as well as the non-selecti
ve inhibitor papaverine were added incremently. There was no spontaneo
us ureteral activity in any ureteral strip examined. Papaverine as wel
l as the selective phosphodiesterase inhibitors relaxed KCI preconract
ed strips dose-dependently with an IC50 of 30 mu M for papaverine, 40
mu M for zaprinast, 25 mu M for quazinone and 0.1 mu M for rolipram. T
hese data show that at low concentrations the phosphodiesterase IV inh
ibitor rolipram was the most potent drug examined. Our findings suppor
t the involvement of cyclic nucleotide metabolism in the regulation of
ureteral smooth muscle tone. The existence of three different isoenzy
mes and their involvement in cyclic nucleotide metabolism in the regul
ation of ureteral smooth muscle tone has been shown. The ureter relaxi
ng effect of specific PDE-IV-inhibitor at low concentrations, combined
with its low effect on the systemic circulatory parameters, may be of
use in treating ureteral colics.